However, there was no significant difference between the Kaplan–Meier survival analysis of S100A10 mRNA levels suggesting that high expression is correlated with shorter overall survival (OS) and recurrence-free survival in breast cancer. The gene discussed is S100A10; the disease is breast carcinoma.